ScoreWhy is Zhejiang Haisen Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 12.10% and Operating profit at 10.18% over the last 5 years
2
Flat results in Sep 25
- INTEREST COVERAGE RATIO(Q) Lowest at 33,772.44
- DEBT-EQUITY RATIO (HY) Highest at -68.73 %
- OPERATING PROFIT(Q) Lowest at CNY 29.17 MM
3
With ROE of 8.96%, it has a very attractive valuation with a 2.54 Price to Book Value
- Over the past year, while the stock has generated a return of 28.59%, its profits have risen by 17%
- At the current price, the company has a high dividend yield of 0.1
4
Market Beating Performance
- The stock has generated a return of 28.59% in the last 1 year, much higher than market (China Shanghai Composite) returns of 15.45%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Zhejiang Haisen Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Specialty Chemicals should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Zhejiang Haisen Pharmaceutical Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Zhejiang Haisen Pharmaceutical Co., Ltd.
32.86%
0.86
52.45%
China Shanghai Composite
16.01%
1.03
14.98%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
12.10%
EBIT Growth (5y)
10.18%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.74
Sales to Capital Employed (avg)
0.33
Tax Ratio
13.44%
Dividend Payout Ratio
9.43%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
32.05%
ROE (avg)
8.77%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
28
Industry P/E
Price to Book Value
2.54
EV to EBIT
20.54
EV to EBITDA
17.84
EV to Capital Employed
5.71
EV to Sales
5.24
PEG Ratio
NA
Dividend Yield
0.05%
ROCE (Latest)
27.79%
ROE (Latest)
8.96%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -15.64% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 7.58 times
-6What is not working for the Company
INTEREST COVERAGE RATIO(Q)
Lowest at 33,772.44
DEBT-EQUITY RATIO
(HY)
Highest at -68.73 %
OPERATING PROFIT(Q)
Lowest at CNY 29.17 MM
PRE-TAX PROFIT(Q)
Lowest at CNY 31.87 MM
NET PROFIT(Q)
Lowest at CNY 27.42 MM
Here's what is working for Zhejiang Haisen Pharmaceutical Co., Ltd.
Debtors Turnover Ratio
Highest at 7.58 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -15.64% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Zhejiang Haisen Pharmaceutical Co., Ltd.
Interest Coverage Ratio
Lowest at 33,772.44
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Operating Profit
Lowest at CNY 29.17 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Pre-Tax Profit
Lowest at CNY 31.87 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CNY MM)
Net Profit
Lowest at CNY 27.42 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
Debt-Equity Ratio
Highest at -68.73 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
